SCHEMBL884871

SCHEMBL884871

CCN1C(=O)CCCc2c(OC)cccc21

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
DRD2 P14416 1/20 0.46
DRD3 P35462 1/20 0.46
THRB P10828 1/20 0.45
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
HTR1A P08908 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTR7 P34969 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
MTNR1A P48039 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL886245 0.89 SIGMAR1 (0.48) NOTUMSIGMAR1DRD2DRD3THRB
SCHEMBL885034 0.82 NOTUM (0.49) NOTUMSIGMAR1DRD2DRD3HDAC1
SCHEMBL12043682 0.78 NOTUM (0.46) NOTUMSIGMAR1DRD2DRD3THRB
SCHEMBL2061889 0.76 ATAD2 (0.45) THRBCYP1A2
SCHEMBL2063114 0.76 PDE4B (0.37)
SCHEMBL21894200 0.75 DRD2 (0.58) SIGMAR1DRD2DRD3THRB
Hydrochloric Acid SCHEMBL12481287 0.75 ATAD2 (0.44) THRBCYP1A2
SCHEMBL8844567 0.75 SIGMAR1 (0.62) SIGMAR1DRD2DRD3MEN1CYP1A2
SCHEMBL14288725 0.75 THRB (0.49) DRD2DRD3THRBMEN1KMT2A
SCHEMBL1764057 0.74 SIGMAR1 (0.58) NOTUMSIGMAR1DRD2DRD3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed